[1] Pastagia M,Schuch R,Fischetti V A,et al.Lysins:the arrival of pathogen-directed anti-infectives[J].Journal of Medical Microbiology,2013,62(10):1506-1516.
[2] Schmelcher M,Donovan D M,Loessner M J.Bacteriophage endolysins as novel antimicrobials[J].Future Microbiology,2012,7(10):1147-1171.
[3] Schuch R,Pelzek A J,Raz A,et al.Use of a bacteriophage lysin to identify a novel target for antimicrobial development[J].PLoS One,2013,8(4):e60754.
[4] Zhang H,Bao H,Billington C,et al.Isolation and lytic activity of the Listeria bacteriophage endolysin LysZ5 against Listeria monocytogenes in soya milk[J].Food Microbiology,2012,31(1):133-136.
[5] Obeso J M,Martinez B,Rodriguez A,et al.Lytic activity of the recombinant staphylococcal bacteriophage Phi H5 endolysin active against Staphylococcus aureus in milk[J].International Journal of Food Microbiology,2008,128(2):212-218.
[6] Singh P K,Donovan D M,Kumar A.Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis[J].Antimicrobial Agents and Chemotherapy,2014,58(8):4621-4629.
[7] Croux C,Ronda C,López R,et al.Interchange of functional domains switches enzyme specificity:construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme[J].Molecular Microbiology,1993,9(5):1019-1025.
[8] Oshida T,Sugai M,Komatsuzawa H,et al.A Staphylococcus aureus autolysin that has an N-acetylmuramoyl-L-alanine amidase domain and an endo-beta-N-acetylglucosaminidase domain:cloning,sequence analysis,and characterization[J].Proceedings of the National Academy of Sciences of the United States of America,1995,92(1):285-289.
[9] Sheehan M M,García J L,López R,et al.Analysis of the catalytic domain of the lysin of the lactococcal bacteriophage Tuc2009 by chimeric gene assembling[J].FEMS Microbiology Letters,1996,140(1):23-28.
[10] Milohanic E,Jonquières R,Cossart P,et al.The autolysin Ami contributes to the adhesion of Listeria monocytogenes to eukaryotic cells via its cell wall anchor[J].Molecular Microbiology,2001,39(5):1212-1224.
[11] Becker S C,Foster-Frey J,Stodola A J,et al.Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain[J].Gene,2009,443(1/2):32-41.
[12] Horgan M,O'flynn G,Garry J,et al.Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci[J].Applied and Environmental Microbiology,2009,75(3):872-874.
[13] Schmelcher M,Shabarova T,Eugster M R,et al.Rapid multiplex detection and differentiation of Listeria cells by use of fluorescent phage endolysin cell wall binding domains[J].Applied and Environmental Microbiology,2010,76(17):5745-5756.
[14] 张志军,曹海燕,刘延媛,等.医院感染金黄色葡萄球菌耐药表型与耐药基因研究[J].中华医院感染学杂志,2015,25(9):1924-1926.
[15] 赵薇,刘桂华,王艳秋,等.食品中单核细胞增生性李斯特菌污染及耐药状况调查[J].中国卫生检验杂志,2012(6):1394-1395.
[16] Romanova N,Favrin S,Griffiths M W.Sensitivity of Listeria monocytogenes to sanitizers used in the meat processing industry[J].Applied and Environmental Microbiology,2002,68(12):6405-6409.
[17] Rodríguez-Rubio L,Martínez B,Rodríguez A,et al.The phage lytic proteins from the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88 display multiple active catalytic domains and do not trigger staphylococcal resistance[J].PLoS One,2013,8(5):e64671.
[18] Shen Y,Mitchell M S,Donovan D M,et al.Phage-based Enzybiotics[M]//Hyman P,Abedon S T.Bacteriophages in health and disease.Wallingford,UK:CAB International,2012:217-239.
[19] Fukushima T,Yao Y,Kitajima T,et al.Characterization of new L,D-endopeptidase gene product CwlK (previous YcdD) that hydrolyzes peptidoglycan in Bacillus subtilis[J].Molecular Genetics and Genomics,2007,278(4):371-383.
[20] Wang S,Gu J,Lv M,et al.The antibacterial activity of E.coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region[J].Journal of Microbiology,2017,55(5):403-408.
[21] Ma Q,Guo Z,Gao C,et al.Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus[J].Antonie Van Leeuwenhoek,2017,110(3):347-355.
[22] Djurkovic S,Loeffler J M,Fischetti V A.Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance[J].Antimicrobial Agents and Chemotherapy,2005,49(3):1225-1228. |